Roivant Sciences Ltd. — Director's Dealing 2023

Jan 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2022-12-30

Reporting Person: Venker Eric (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-30	Common Shares	S	23761	$8	Disposed	848950	Direct
2023-01-03	Common Shares	S	95484	$7.32	Disposed	753466	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022.

F2: A Form 4 filed by the reporting person on December 28, 2022 inadvertently overstated the total number of Common Shares held by the reporting person by 28,936 Common Shares. The updated amounts reported here correct that error and reflect the reporting person's holdings.